Abstract
During the past few years, Lewis-acidic ionic liquids (ILs) have emerged from their role as mere reaction media toward a role as novel catalytic systems. Iron-containing chloroferrate ionic liquids in particular offer a novel approach to sustainable and environmentally benign catalysis and can be applied in a surprising diversity of transformations. In this review, we present this emerging topic and report the application of chloroferrate ILs as solvents, catalysts or catalytic systems for a variety of chemical processes, with a particular focus on reactions leading to pharmaceutically active compounds or intermediates.
Keywords: Catalysis, Chloroferrate, Ionic liquids, Synthesis, Sustainable Catalysis, Solvent, 1.1. Friedel, –, Crafts Acylation
Current Organic Synthesis
Title: From Solvent to Sustainable Catalysis - Chloroferrate Ionic Liquids in Synthesis
Volume: 8 Issue: 6
Author(s): Katharina Bica, Sonja Leder and Peter Gaertner
Affiliation:
Keywords: Catalysis, Chloroferrate, Ionic liquids, Synthesis, Sustainable Catalysis, Solvent, 1.1. Friedel, –, Crafts Acylation
Abstract: During the past few years, Lewis-acidic ionic liquids (ILs) have emerged from their role as mere reaction media toward a role as novel catalytic systems. Iron-containing chloroferrate ionic liquids in particular offer a novel approach to sustainable and environmentally benign catalysis and can be applied in a surprising diversity of transformations. In this review, we present this emerging topic and report the application of chloroferrate ILs as solvents, catalysts or catalytic systems for a variety of chemical processes, with a particular focus on reactions leading to pharmaceutically active compounds or intermediates.
Export Options
About this article
Cite this article as:
Bica Katharina, Leder Sonja and Gaertner Peter, From Solvent to Sustainable Catalysis - Chloroferrate Ionic Liquids in Synthesis, Current Organic Synthesis 2011; 8 (6) . https://dx.doi.org/10.2174/1570179411108060824
DOI https://dx.doi.org/10.2174/1570179411108060824 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Beyond Cholesterol Lowering: Pleiotropic Effects of Bile Acid Binding Resins Against Cardiovascular Disease Risk Factors in Patients with Metabolic Syndrome
Current Vascular Pharmacology Anti-Inflammatory and Antioxidant Effects of Resveratrol in Healthy Smokers A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
Current Medicinal Chemistry Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Current Cancer Drug Targets Systemic Biomarkers in the Evaluation and Management of COPD Patients: Are We Getting Closer to Clinical Application?
Current Drug Targets The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety Comparison and Impact of The Short-Term Use of Some Non-Aspirin NSAIDs on Bleeding Time of Mice
Cardiovascular & Hematological Agents in Medicinal Chemistry Applications and Toxicity of Silver Nanoparticles: A Recent Review
Current Topics in Medicinal Chemistry TGF-β2 Signaling in High-Grade Gliomas
Current Pharmaceutical Biotechnology Mechanisms Leading to COX-2 Expression and COX-2 Induced Tumorigenesis: Topical Therapeutic Strategies Targeting COX-2 Expression and Activity
Anti-Cancer Agents in Medicinal Chemistry Role of Dendritic Cell-Derived Cytokines in Immune Regulation
Current Pharmaceutical Design A Review on Clinical Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Natalizumab: A Humanized Anti-α4 Integrin Monoclonal Antibody
Current Drug Metabolism Immunokinases, a Novel Class of Immunotherapeutics for Targeted Cancer Therapy
Current Pharmaceutical Design Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies
Current Molecular Medicine Development, Validation and Results of Quantitative Stability Testing for Gastrografin<sup>®</sup>
Current Pharmaceutical Analysis Regeneration of Pancreatic β-Cells in vivo as a Potential Therapeutic Approach for Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Fatty Acid-Binding Proteins at a Glance
Protein & Peptide Letters Biologics in Inflammatory and Immunomediated Arthritis
Current Pharmaceutical Biotechnology Peptide Metabolism and the Control of Body Fluid Homeostasis
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Current Evidence for Antithrombotic Therapy after Peripheral Vascular Interventions
Current Vascular Pharmacology